Abstract:The hydrazine s-triazine ligand (E)-4,4’-(6-(2-(1-(pyridin-2-yl)ethylidene)hydrazinyl)-1,3,5-triazine-2,4-diyl)dimorpholine (DMPT) was used to synthesize two new Ni(II) complexes via a self-assembly technique. The two complexes were synthesized by a one-pot synthesis strategy and characterized by elemental analysis, FTIR and single-crystal X-ray diffraction analysis to be [Ni(DMPT)(H2O)3](NO3)2.3H2O (1) and [Ni(DMPT)(H2O)3](NO3)2.H2O (2). The structures of both complexes were very similar regarding the coordination sphere and counter anions, but differ only in the number of the crystal water molecules. In the case of complex 1, there are three water molecules instead of one H2O molecule as in complex 2. In the two complexes, the DMPT ligand acts as a neutral tridentate NNN-chelate via three Ni–N coordination interactions. The coordination sphere of the Ni(II) ion is completed by three water molecules. As a result, the two complexes exhibit distorted octahedral geometry. The Hirshfeld surfaces around each entity in both complexes have been computed. Subsequently, their corresponding intermolecular interactions were quantified separately. Because the number of crystal water molecules is different in both complexes, their monomeric units are connected differently in their crystal structures where the crystal water molecules act as both hydrogen bond donor and acceptor. The polar O...H interactions are the most dominant in all entities of both complexes. As a result, strong O...H interactions are the driving force in the crystal packing of both complexes, and this is attributed to the presence of the nitrate anions and water molecules. The antimicrobial activity of the free ligand and complex 1 were determined against two selected fungal species, Gram-negative and Gram-positive bacterial strains. The free ligand was found to be inactive against all microbial species. On the other hand, the Ni(II) complex 1 was found active against the Gram-positive bacterial species Bacillus subtilis and also the Gram-negative bacterial species Escherichia coli. The respective inhibition zone diameter of the Ni(II) complex was 12 and 11 mm, respectively.

Synthesis, Crystal Structures, DFT Studies, Molecular Docking and Urease Inhibition Studies of Three Ni(II) Complexes with a Sexidentate N2O4-donor Bis-Schiff Base Ligand

Synthesis, Crystal Structures, Molecular Docking and Urease Inhibitory Activity of Nickel(ii) Complexes with 3-Pyridinyl-4-amino-5-mercapto-1,2,4-triazole

Urease inhibition studies of six Ni(II), Co(II) and Cu(II) complexes with two sexidentate N<sub>2</sub>O<sub>4</sub>-donor bis-Schiff base ligands: An experimental and DFT computational study

Synthesis, Structures and Urease Inhibition Studies of Copper(ii) and Nickel(ii) Complexes with Bidentate N,O-donor Schiff Base Ligands.

Synthesis, structure, and biological evaluation of three Cu(II) and Ni(II) (E)-3-(3,4-dimethoxyphenyl)acrylate complexes with organic diamines as potential urease inhibitors

Synthesis, Crystal Structures, Molecular Docking, and in Vitro Biological Activities Evaluation of Transition Metal Complexes with 4-(3,4-dichlorophenyl) Piperazine-1-Carboxylic Acid

Synthesis and Biological Evaluation of Cu(Ii), Zn(Ii), and Ni(Ii) 3-(4-nitrophenyl)acrylic Acid Complexes with Diamines As Potential Urease Inhibitors

Synthesis, Crystal Structure, and Urease Inhibition Studies of Copper(Ii) and Cobalt(Iii) Complexes with Bi(2-Fluorobenzylaminoethyl)Amine

Synthesis, Structure, and Urease Inhibitory Activities of Three Binuclear Copper(ii) Complexes with Protocatechuic Acid Derivative

Three Zn(II) Complexes with a Sexidentate N 2 O 4 -Donor Bis-Schiff Base Ligand: Synthesis, Characterization, DFT Studies, in Vitro Antimicrobial Evaluation and Molecular Docking Studies

Synthesis, Molecular Docking, and Inhibitory Activity of a Ni Schiff-base Complex Against Urease

Synthesis, crystal structures and urease inhibition of nickel(II), copper(II), zinc(II) and molybdenum(VI) complexes derived from N,n'-bis(4-bromosalicylidene)-1,3-propanediamine

Transition Metal Complexes (m=cu, Ni and Mn) of Schiff-base Ligands: Syntheses, Crystal Structures, and Inhibitory Bioactivities Against Urease and Xanthine Oxidase

Synthesis, Molecular Docking and Biological Evaluation of Schiff Base Transition Metal Complexes As Potential Urease Inhibitors

Synthesis, Characterization and Crystal Structures of Schiff Base Copper Complexes with Urease Inhibitory Activity

New Method for the Synthesis of A Mononucleating Cyclic Peptide Ligand, Crystal Structures of Its Ni, Zn, Cu, and Co Complexes, and Their Inhibitory Bioactivity Against Urease

Synthesis, Crystal Structure and Urease Inhibitory Activities of Schiff Base Metal Complexes

Synthesis, Crystal Structures, Molecular Docking, in Vitro Monoamine Oxidase-B Inhibitory Activity of Transition Metal Complexes with 2-{4-[bis (4-Fluorophenyl)methyl]piperazin-1-yl} Acetic Acid

Synthesis, Structure, Urease Inhibitory, and Cytotoxic Activities of Two Complexes with Protocatechuic Acid Derivative and Phenanthroline

Molecular docking and biological activities of Ni(II), Cu(II) and Co(II) complexes with a new potentially hexadentate polyamine ligand; X-ray crystal structure of the Cu(II) complex

Synthesis, X-ray Structure of Two Hexa-Coordinated Ni(II) Complexes with s-Triazine Hydrazine Schiff Base Ligand